about
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...
Read More
1.94
0.01
(0.52%)
260.3K
XNAS Volume
XNAS 21 Sep, 2026 4:00 PM (EDT)
Board Meeting
The next board meeting for GRI Bio Inc is on 24 Sep 2026 for the purpose of GRI Bio Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
GRI Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..